• Skip to primary navigation
  • Skip to main content
  • Skip to footer
ARVC Studies

ARVC Studies

  • About ARVC
    • Overview
    • Causes
    • Symptoms
    • Diagnosis
  • Gene Therapy for ARVC
    • Basic Genetics
    • Mutations & Disease
    • Gene Therapy
    • AAV Capsids
    • TN-401 for ARVC
  • Our Studies
    • RIDGE-1
    • RIDGE
  • Resources
  • Contact Us
Contact Us

Share this page:

For more information about Tenaya’s clinical programs, complete this form or contact Wendy on our Patient Advocacy team by email or phone at (650) 825-6990 option 4.  THIS WEBSITE IS INTENDED FOR U.S. AUDIENCES ONLY.

Wendy Borsari, Associate Director of Patient Advocacy, Living with genetic HCM, community advocate for over a decade

Contact Us

The Patient Advocacy team at Tenaya is here to support patients and their families. If you are a U.S. resident and would like to learn more about our clinical programs or have questions for us, please fill out the form below.

If you prefer to contact us directly or live outside of the United States, please email patient.advocacy@tenayathera.com or call (650) 825-6990 and select option 4.

Please tell us about yourself.

Footer

  • X formerly twitter
  • LinkedIn
  • Facebook
  • Instagram

This website is a service of Tenaya Therapeutics, Inc., a clinical-stage biotechnology company committed to a bold mission: to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease. Website is intended for U.S. Audiences only.

  • Expanded Access Policy
  • Privacy Policy
  • Cookie Policy
  • Terms & Conditions
  • Community Guidelines

© 2024 Tenaya Therapeutics. All rights reserved
Last Updated November 25, 2024